Stevan G. Severtson, Ph.D. - Publications

Affiliations: 
2009 Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Mental Health

16/49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lait MCL, Severtson SG, Dasgupta N, Green JL, Hall A, Dart RC. The street prices of immediate- and extended-release tapentadol are lower than other schedule II opioid tablets/capsules Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.382  0.307
2012 Whitaker D, Graham C, Severtson SG, Furr-Holden CD, Latimer W. Neighborhood & Family Effects on Learning Motivation among Urban African American Middle School Youth. Journal of Child and Family Studies. 21: 131-138. PMID 22389576 DOI: 10.1007/S10826-011-9456-1  0.633
2012 Severtson SG, Hedden SL, Martins SS, Latimer WW. Patterns of cognitive impairments among heroin and cocaine users: the association with self-reported learning disabilities and infectious disease. Journal of Learning Disabilities. 45: 139-50. PMID 20574063 DOI: 10.1177/0022219409355481  0.579
2011 Hedden SL, Whitaker DE, Von Thomsen S, Severtson SG, Latimer WW. Latent patterns of risk behavior in Urban African-American middle school students in Baltimore city Journal of Child and Adolescent Substance Abuse. 20: 34-47. DOI: 10.1080/1067828X.2011.534358  0.577
2010 Severtson SG, von Thomsen S, Hedden SL, Latimer W. The association between executive functioning and motivation to enter treatment among regular users of heroin and/or cocaine in Baltimore, MD Addictive Behaviors. 35: 717-720. PMID 20226598 DOI: 10.1016/J.Addbeh.2010.02.012  0.657
2010 Severtson SG, Mitchell MM, Hubert A, Latimer W. The relationship between performance on the Shipley Institute of Living Scale (SILS) and hepatitis C infection among active injection drug users in Baltimore, Maryland. The American Journal of Drug and Alcohol Abuse. 36: 61-5. PMID 20141399 DOI: 10.3109/00952990903573264  0.69
2009 Latimer WW, Hedden SL, Floyd L, Lawson A, Melnikov A, Severtson SG, Moleko AG, Cole K. Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity. Journal of Drug Issues. 39: 893-904. PMID 20473343 DOI: 10.1177/002204260903900406  0.639
2009 Severtson SG, Mitchell MM, Mancha BE, Latimer WW. The association between planning abilities and sharing injection drug use equipment among injection drug users in Baltimore, MD Journal of Substance Use. 14: 325-333. DOI: 10.3109/14659890802668763  0.722
2009 Latimer WW, Hedden SL, Moleko AG, Floyd L, Lawson A, Melnikov A, Severtson SG, Cole K. Prevalence and correlates of hepatitis C among in jection drug users: The significance of duration of use, incarceration, and race/ ethnicity Journal of Drug Issues. 39: 893-904.  0.664
2008 Mitchell MM, Severtson SG, Latimer WW. Pregnancy and race/ethnicity as predictors of motivation for drug treatment. The American Journal of Drug and Alcohol Abuse. 34: 397-404. PMID 18584569 DOI: 10.1080/00952990802082172  0.576
2008 Severtson SG, Latimer WW. Factors related to correctional facility incarceration among active injection drug users in Baltimore, MD. Drug and Alcohol Dependence. 94: 73-81. PMID 18082337 DOI: 10.1016/J.Drugalcdep.2007.10.007  0.696
2007 Latimer WW, Moleko AG, Melnikov A, Mitchell M, Severtson SG, von Thomsen S, Graham C, Alama D, Floyd L. Prevalence and correlates of hepatitis A among adult drug users: The significance of incarceration and race/ethnicity Vaccine. 25: 7125-7131. PMID 17766016 DOI: 10.1016/J.Vaccine.2007.07.041  0.727
2007 Mitchell MM, Severtson SG, Latimer WW. Interaction of cognitive performance and knowing someone who has died from AIDS on HIV risk behaviors. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 19: 289-97. PMID 17685842 DOI: 10.1521/Aeap.2007.19.4.289  0.633
2006 Severtson S, Graham C, Mitchell M, Floyd L, Latimer W. Factors associated with HIV and HCV infection among individuals with a history of injection drug use in Baltimore Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-P59  0.712
2006 Mitchell M, Severtson S, Graham C, Floyd L, Latimer W. The moderating influence of cognitive performance on risk awareness to predict HIV/AIDS risk-taking behaviors Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-P41  0.656
2006 Graham C, Severtson S, Mitchell M, Floyd L, Latimer W. Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-P21  0.729
Low-probability matches (unlikely to be authored by this person)
2016 Severtson SG, Ellis MS, Kurtz SP, Rosenblum A, Cicero TJ, Parrino MW, Gilbert MK, Buttram ME, Dasgupta N, BucherBartelson B, Green JL, Dart RC. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug and Alcohol Dependence. 168: 219-229. PMID 27716575 DOI: 10.1016/J.Drugalcdep.2016.09.018  0.278
2014 Davis JM, Severtson SG, Bucher-Bartelson B, Dart RC. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits. Pharmacoepidemiology and Drug Safety. 23: 18-25. PMID 24130046 DOI: 10.1002/pds.3533  0.255
2017 Dart RC, Bartelson BB, Severtson SG, Bau G, Green JL. Increasing abuse of gabapentin and pregabalin as reported to U.S. poison centers 2006 through 2014 Drug and Alcohol Dependence. 171. DOI: 10.1016/J.Drugalcdep.2016.08.152  0.246
2012 Aklin WM, Severtson SG, Umbricht A, Fingerhood M, Bigelow GE, Lejuez CW, Silverman K. Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence. The Journal of Clinical Psychiatry. 73: e1056-61. PMID 22967782 DOI: 10.4088/Jcp.09M05807  0.238
2015 Chilcoat H, Bartelson BB, Severtson SG, Butler SF, Cassidy T, Coplan P. Trends in abuse and diversion in multiple surveillance systems three years after introduction of reformulated OxyContin Drug and Alcohol Dependence. 146: e246. DOI: 10.1016/J.Drugalcdep.2014.09.135  0.235
2013 Severtson SG, Bartelson BB, Davis JM, Muñoz A, Schneider MF, Chilcoat H, Coplan PM, Surratt H, Dart RC. Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. The Journal of Pain : Official Journal of the American Pain Society. 14: 1122-30. PMID 23816949 DOI: 10.1016/J.Jpain.2013.04.011  0.23
2022 Fischer LJ, Severtson SG, Gurrola MC, Iwanicki JL, Green JL, Dart RC. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014. Substance Use & Misuse. 57: 1097-1103. PMID 35450512 DOI: 10.1080/10826084.2022.2063898  0.227
2014 Lavonas EJ, Severtson SG, Martinez EM, Bucher-Bartelson B, Le Lait MC, Green JL, Murrelle LE, Cicero TJ, Kurtz SP, Rosenblum A, Surratt HL, Dart RC. Abuse and diversion of buprenorphine sublingual tablets and film. Journal of Substance Abuse Treatment. 47: 27-34. PMID 24680219 DOI: 10.1016/j.jsat.2014.02.003  0.212
2015 Severtson SG, Lait MCL, Green JL, Dart RC. Regional concentrations of Opana® ER abuse before and after introduction of a tamper-resistant formulation in 2012 Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.625  0.209
2015 Iwanicki JL, Lait MCL, Severtson SG, Bucher-Bartelson B, Dart RC. Prescription opioid death rates are greater for females than males Drug and Alcohol Dependence. 156. DOI: 10.1016/J.Drugalcdep.2015.07.284  0.171
2017 Vosburg SK, Severtson SG, Dart RC, Cicero TJ, Kurtz SP, Parrino MW, Green JL. Assessment of Tapentadol API Abuse Liability with the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System. The Journal of Pain : Official Journal of the American Pain Society. PMID 29224919 DOI: 10.1016/j.jpain.2017.11.007  0.166
2015 West NA, Severtson SG, Green JL, Dart RC. Trends in abuse and misuse of prescription opioids among older adults. Drug and Alcohol Dependence. 149: 117-21. PMID 25678441 DOI: 10.1016/j.drugalcdep.2015.01.027  0.153
2014 Le Lait MC, Martinez EM, Severtson SG, Lavery SA, Bucher-Bartelson B, Dart RC. Assessment of prescription opioid intentional exposures across the rural-urban continuum in the United States using both population and drug availability rates. Pharmacoepidemiology and Drug Safety. 23: 1334-7. PMID 24899151 DOI: 10.1002/pds.3653  0.149
2018 Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone. Pharmacoepidemiology and Drug Safety. PMID 29766592 DOI: 10.1002/pds.4558  0.146
2014 Davis JM, Searles VB, Severtson SG, Dart RC, Bucher-Bartelson B. Seasonal variation in suicidal behavior with prescription opioid medication. Journal of Affective Disorders. 158: 30-6. PMID 24655762 DOI: 10.1016/j.jad.2014.01.010  0.135
2018 Butler SF, Black RA, Severtson SG, Dart RC, Green JL. Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers. Journal of Substance Abuse Treatment. 84: 42-49. PMID 29195592 DOI: 10.1016/j.jsat.2017.10.010  0.125
2012 Goldschmidt L, Richardson GA, Willford JA, Severtson SG, Day NL. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicology and Teratology. 34: 161-7. PMID 21884785 DOI: 10.1016/J.Ntt.2011.08.009  0.123
2023 Atreja N, Severtson SG, Jiang J, Gao C, Hines DM, Cheng D, Hagan M, Breeze JL, Paulus JK, Secemsky EA. The Association between Direct Oral Anticoagulants Prescribing Behavior and Non-Valvular Atrial Fibrillation Outcomes: An Instrumental Variable Analysis of Real-World Data. Journal of Clinical Medicine. 12. PMID 38002802 DOI: 10.3390/jcm12227190  0.121
2018 Calcaterra SL, Severtson SG, Bau GE, Margolin ZR, Bucher-Bartelson B, Green JL, Dart RC. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clinical Toxicology (Philadelphia, Pa.). 1-8. PMID 29609498 DOI: 10.1080/15563650.2018.1457792  0.104
2014 Severtson SG, Bucher-Bartelson B, Dart RC. Age trends in abuse calls to poison centers involving prescription opioids Drug and Alcohol Dependence. 140: e203. DOI: 10.1016/j.drugalcdep.2014.02.566  0.078
2012 Chilcoat H, Bartelson BB, Coplan P, Dart R, Davis J, Green J, Muñoz A, Schneider MF, Severtson S. Poster 99 Difference in Rates of Abuse Following Reformulation of Extended Release Oxycodone Using Data from the Radars® System Poison Center Program Pm&R. 4: S223-S223. DOI: 10.1016/J.Pmrj.2012.09.724  0.078
2012 Severtson S, Bartelson B, Davis J, Munoz A, Schneider M, Coplan P, Chilcoat H, Green J, Dart R. 92 Difference in Rates of Abuse Following Reformulation of Extended Release Oxycodone Using Data From the RADARS® System Poison Center Program Annals of Emergency Medicine. 60: S34-S35. DOI: 10.1016/J.Annemergmed.2012.06.371  0.077
2021 Buttram ME, Kurtz SP, Margolin ZR, Severtson SG. Increasing rates of buprenorphine diversion in the United States, 2002 to 2019. Pharmacoepidemiology and Drug Safety. PMID 34302707 DOI: 10.1002/pds.5334  0.07
2015 Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. The New England Journal of Medicine. 372: 241-8. PMID 25587948 DOI: 10.1056/NEJMsa1406143  0.065
2022 Palamar JJ, Cottler LB, Goldberger BA, Severtson SG, Grundy DJ, Iwanicki JL, Ciccarone D. Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 35704785 DOI: 10.1080/00952990.2022.2081923  0.063
2014 Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Green JL. SY01-2 * BENDING THE CURVE OF OPIOID ANALGESIC ABUSE IN THE UNITED STATES Alcohol and Alcoholism. 49: i3-i3. DOI: 10.1093/alcalc/agu052.2  0.054
2015 Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States New England Journal of Medicine. 372: 1573-1574. PMID 25875268 DOI: 10.1056/NEJMc1501822  0.05
2023 Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA ER versus other opioid analgesics. Pain Management. 13: 519-527. PMID 37850331 DOI: 10.2217/pmt-2022-0068  0.047
2018 Murphy DL, Lebin JA, Severtson SG, Olsen HA, Dasgupta N, Dart RC. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics. Drug Safety. PMID 29582394 DOI: 10.1007/s40264-018-0660-4  0.036
2012 Chilcoat H, Bucher Bartelson B, Coplan P, Dart R, Davis J, Green J, Muñoz A, Schneider MF, Severtson S, Surratt H. Poster 282 Changes in Diversion Rates Following the Introduction of a Reformulated Extended-Release Oxycodone Product Pm&R. 4: S285-S285. DOI: 10.1016/J.Pmrj.2012.09.895  0.027
2012 Davis J, Severtson S, Bartelson B, Munoz A, Schneider M, Surratt H, Coplan P, Chilcoat H, Green J, Dart R. 93 Changes in Diversion Rates Following the Introduction of a Reformulated Extended Release Oxycodone Product Annals of Emergency Medicine. 60: S35. DOI: 10.1016/J.Annemergmed.2012.06.372  0.026
2018 Wang GS, Severtson SG, Bau GE, Dart RC, Green JL. Unit-Dose Packaging and Unintentional Buprenorphine-Naloxone Exposures. Pediatrics. PMID 29724879 DOI: 10.1542/peds.2017-4232  0.023
2012 Severtson S, Bucher-Bartelson B, Chilcoat H, Coplan P, Surratt H, Dart R. A comparison of the street price of original and reformulated OxyContin® and immediate release (IR) oxycodone products The Journal of Pain. 13: S26. DOI: 10.1016/J.Jpain.2012.01.112  0.021
Hide low-probability matches.